Search Results Search Sort by RelevanceMost Recent Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503. Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311. Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609. Policy Forum Apr 2003 A Responsible Patient Swathi Arekapudi Virtual Mentor. 2003;5(4):144-146. doi: 10.1001/virtualmentor.2003.5.4.pfor1-0304. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Policy Forum Mar 2005 Confidentiality and Consent in Adolescent Substance Abuse: An Update Melissa Weddle, MD, MPH and Patricia K. Kokotailo, MD, MPH Virtual Mentor. 2005;7(3):239-243. doi: 10.1001/virtualmentor.2005.7.3.pfor1-0503.
Policy Forum Nov 2003 "You Can Pay Me Now, Or You Can Pay Me Later" Geoffrey C. Williams, MD, PhD Virtual Mentor. 2003;5(11):518-522. doi: 10.1001/virtualmentor.2003.5.11.pfor2-0311.
Policy Forum Sep 2016 Shared Responsibility: Massachusetts Legislators, Physicians, and An Act Relative to Substance Use Treatment, Education, and Prevention Meghan Rudder, MD, Lulu Tsao, MD, and Helen E. Jack Massachusetts legislation limiting supply of first-time opioid prescriptions creates opportunity for interprofessional collaboration on drug policy. AMA J Ethics. 2016;18(9):950-959. doi: 10.1001/journalofethics.2016.18.9.pfor2-1609.
Policy Forum Apr 2003 A Responsible Patient Swathi Arekapudi Virtual Mentor. 2003;5(4):144-146. doi: 10.1001/virtualmentor.2003.5.4.pfor1-0304.